Research ExplorerPublicationsImproving outcomes of childhood and young adult non-Hodgkin ...

Improving outcomes of childhood and young adult non-Hodgkin lymphoma: 25 years of research and collaboration within the framework of the European Intergroup for Childhood Non-Hodgkin Lymphoma

Standard

Improving outcomes of childhood and young adult non-Hodgkin lymphoma: 25 years of research and collaboration within the framework of the European Intergroup for Childhood Non-Hodgkin Lymphoma. / Beishuizen, Auke; Mellgren, Karin; Andrés, Mara; Auperin, Anne; Bacon, Chris M; Bomken, Simon; Burke, G A Amos; Burkhardt, Birgit; Brugieres, Laurence; Chiang, Alan K S; Damm-Welk, Christine; d'Amore, Emanuele; Horibe, Keizo; Kabickova, Edita; Khanam, Tasneem; Kontny, Udo; Klapper, Wolfram; Lamant, Laurence; Le Deley, Marie-Cecile; Loeffen, Jan; Macintyre, Elizabeth; Mann, Georg; Meyer-Wentrup, Friederike; Michgehl, Ulf; Minard-Colin, Veronique; Mussolin, Lara; Oschlies, Ilske; Patte, Catherine; Pillon, Marta; Reiter, Alfred; Rigaud, Charlotte; Roncery, Leila; Salaverria, Itziar; Simonitsch-Klupp, Ingrid; Uyttebroeck, Anne; Verdu-Amoros, Jaime; Williams, Denise; Woessmann, Wilhelm; Wotherspoon, Andrew; Wrobel, Grazyna; Zimmermann, Martin; Attarbaschi, Andishe; Turner, Suzanne D; European Intergroup for Childhood Non-Hodgkin Lymphoma.

In: LANCET HAEMATOL, Vol. 10, No. 3, 03.2023, p. e213-e224.

Research output: SCORING: Contribution to journal › SCORING: Review article › Research

Harvard

Beishuizen, A, Mellgren, K, Andrés, M, Auperin, A, Bacon, CM, Bomken, S, Burke, GAA, Burkhardt, B, Brugieres, L, Chiang, AKS, Damm-Welk, C, d'Amore, E, Horibe, K, Kabickova, E, Khanam, T, Kontny, U, Klapper, W, Lamant, L, Le Deley, M-C, Loeffen, J, Macintyre, E, Mann, G, Meyer-Wentrup, F, Michgehl, U, Minard-Colin, V, Mussolin, L, Oschlies, I, Patte, C, Pillon, M, Reiter, A, Rigaud, C, Roncery, L, Salaverria, I, Simonitsch-Klupp, I, Uyttebroeck, A, Verdu-Amoros, J, Williams, D, Woessmann, W, Wotherspoon, A, Wrobel, G, Zimmermann, M, Attarbaschi, A, Turner, SD & European Intergroup for Childhood Non-Hodgkin Lymphoma 2023, 'Improving outcomes of childhood and young adult non-Hodgkin lymphoma: 25 years of research and collaboration within the framework of the European Intergroup for Childhood Non-Hodgkin Lymphoma', LANCET HAEMATOL, vol. 10, no. 3, pp. e213-e224. https://doi.org/10.1016/S2352-3026(22)00374-X

APA

Beishuizen, A., Mellgren, K., Andrés, M., Auperin, A., Bacon, C. M., Bomken, S., Burke, G. A. A., Burkhardt, B., Brugieres, L., Chiang, A. K. S., Damm-Welk, C., d'Amore, E., Horibe, K., Kabickova, E., Khanam, T., Kontny, U., Klapper, W., Lamant, L., Le Deley, M-C., ... European Intergroup for Childhood Non-Hodgkin Lymphoma (2023). Improving outcomes of childhood and young adult non-Hodgkin lymphoma: 25 years of research and collaboration within the framework of the European Intergroup for Childhood Non-Hodgkin Lymphoma. LANCET HAEMATOL, 10(3), e213-e224. https://doi.org/10.1016/S2352-3026(22)00374-X

Vancouver

Beishuizen A, Mellgren K, Andrés M, Auperin A, Bacon CM, Bomken S et al. Improving outcomes of childhood and young adult non-Hodgkin lymphoma: 25 years of research and collaboration within the framework of the European Intergroup for Childhood Non-Hodgkin Lymphoma. LANCET HAEMATOL. 2023 Mar;10(3):e213-e224. https://doi.org/10.1016/S2352-3026(22)00374-X

Bibtex

@article{90b9cc230e7b42f3bab189367995a945,
title = "Improving outcomes of childhood and young adult non-Hodgkin lymphoma: 25 years of research and collaboration within the framework of the European Intergroup for Childhood Non-Hodgkin Lymphoma",
abstract = "The European Intergroup for Childhood Non-Hodgkin Lymphoma (EICNHL) was established 25 years ago with the goal to facilitate clinical trials and research collaborations in the field both within Europe and worldwide. Since its inception, much progress has been made whereby major improvements in outcomes have been achieved. In this Review, we describe the different diagnostic entities of non-Hodgkin lymphoma in children and young adults describing key features of each entity and outlining clinical achievements made in the context of the EICNHL framework. Furthermore, we provide an overview of advances in biopathology with an emphasis on the role of biological studies and how they have shaped available treatments. Finally, for each entity, we describe future goals, upcoming clinical trials, and highlight areas of research that require our focus going forward.",
keywords = "Child, Humans, Young Adult, Lymphoma, Non-Hodgkin, Europe",
author = "Auke Beishuizen and Karin Mellgren and Mara Andr{\'e}s and Anne Auperin and Bacon, {Chris M} and Simon Bomken and Burke, {G A Amos} and Birgit Burkhardt and Laurence Brugieres and Chiang, {Alan K S} and Christine Damm-Welk and Emanuele d'Amore and Keizo Horibe and Edita Kabickova and Tasneem Khanam and Udo Kontny and Wolfram Klapper and Laurence Lamant and {Le Deley}, Marie-Cecile and Jan Loeffen and Elizabeth Macintyre and Georg Mann and Friederike Meyer-Wentrup and Ulf Michgehl and Veronique Minard-Colin and Lara Mussolin and Ilske Oschlies and Catherine Patte and Marta Pillon and Alfred Reiter and Charlotte Rigaud and Leila Roncery and Itziar Salaverria and Ingrid Simonitsch-Klupp and Anne Uyttebroeck and Jaime Verdu-Amoros and Denise Williams and Wilhelm Woessmann and Andrew Wotherspoon and Grazyna Wrobel and Martin Zimmermann and Andishe Attarbaschi and Turner, {Suzanne D} and {European Intergroup for Childhood Non-Hodgkin Lymphoma}",
note = "Copyright {\textcopyright} 2023 Elsevier Ltd. All rights reserved.",
year = "2023",
month = mar,
doi = "10.1016/S2352-3026(22)00374-X",
language = "English",
volume = "10",
pages = "e213--e224",
journal = "LANCET HAEMATOL",
issn = "2352-3026",
publisher = "Lancet Publishing Group",
number = "3",

}

RIS

TY - JOUR

T1 - Improving outcomes of childhood and young adult non-Hodgkin lymphoma: 25 years of research and collaboration within the framework of the European Intergroup for Childhood Non-Hodgkin Lymphoma

AU - Beishuizen, Auke

AU - Mellgren, Karin

AU - Andrés, Mara

AU - Auperin, Anne

AU - Bacon, Chris M

AU - Bomken, Simon

AU - Burke, G A Amos

AU - Burkhardt, Birgit

AU - Brugieres, Laurence

AU - Chiang, Alan K S

AU - Damm-Welk, Christine

AU - d'Amore, Emanuele

AU - Horibe, Keizo

AU - Kabickova, Edita

AU - Khanam, Tasneem

AU - Kontny, Udo

AU - Klapper, Wolfram

AU - Lamant, Laurence

AU - Le Deley, Marie-Cecile

AU - Loeffen, Jan

AU - Macintyre, Elizabeth

AU - Mann, Georg

AU - Meyer-Wentrup, Friederike

AU - Michgehl, Ulf

AU - Minard-Colin, Veronique

AU - Mussolin, Lara

AU - Oschlies, Ilske

AU - Patte, Catherine

AU - Pillon, Marta

AU - Reiter, Alfred

AU - Rigaud, Charlotte

AU - Roncery, Leila

AU - Salaverria, Itziar

AU - Simonitsch-Klupp, Ingrid

AU - Uyttebroeck, Anne

AU - Verdu-Amoros, Jaime

AU - Williams, Denise

AU - Woessmann, Wilhelm

AU - Wotherspoon, Andrew

AU - Wrobel, Grazyna

AU - Zimmermann, Martin

AU - Attarbaschi, Andishe

AU - Turner, Suzanne D

AU - European Intergroup for Childhood Non-Hodgkin Lymphoma

N1 - Copyright © 2023 Elsevier Ltd. All rights reserved.

PY - 2023/3

Y1 - 2023/3

N2 - The European Intergroup for Childhood Non-Hodgkin Lymphoma (EICNHL) was established 25 years ago with the goal to facilitate clinical trials and research collaborations in the field both within Europe and worldwide. Since its inception, much progress has been made whereby major improvements in outcomes have been achieved. In this Review, we describe the different diagnostic entities of non-Hodgkin lymphoma in children and young adults describing key features of each entity and outlining clinical achievements made in the context of the EICNHL framework. Furthermore, we provide an overview of advances in biopathology with an emphasis on the role of biological studies and how they have shaped available treatments. Finally, for each entity, we describe future goals, upcoming clinical trials, and highlight areas of research that require our focus going forward.

AB - The European Intergroup for Childhood Non-Hodgkin Lymphoma (EICNHL) was established 25 years ago with the goal to facilitate clinical trials and research collaborations in the field both within Europe and worldwide. Since its inception, much progress has been made whereby major improvements in outcomes have been achieved. In this Review, we describe the different diagnostic entities of non-Hodgkin lymphoma in children and young adults describing key features of each entity and outlining clinical achievements made in the context of the EICNHL framework. Furthermore, we provide an overview of advances in biopathology with an emphasis on the role of biological studies and how they have shaped available treatments. Finally, for each entity, we describe future goals, upcoming clinical trials, and highlight areas of research that require our focus going forward.

KW - Child

KW - Humans

KW - Young Adult

KW - Lymphoma, Non-Hodgkin

KW - Europe

U2 - 10.1016/S2352-3026(22)00374-X

DO - 10.1016/S2352-3026(22)00374-X

M3 - SCORING: Review article

C2 - 36858678

VL - 10

SP - e213-e224

JO - LANCET HAEMATOL

JF - LANCET HAEMATOL

SN - 2352-3026

IS - 3

ER -